Warburg meets non-coding RNAs: the emerging role of ncRNA in regulating the glucose metabolism of cancer cells
- PMID: 25431262
- DOI: 10.1007/s13277-014-2875-z
Warburg meets non-coding RNAs: the emerging role of ncRNA in regulating the glucose metabolism of cancer cells
Abstract
Unlike normal differentiated cells, cancer cells primarily rely on glycolysis to generate energy needed for cellular processes even in normoxia conditions. This phenomenon is called aerobic glycolysis or "the Warburg effect." Aerobic glycolysis is inefficient to generate ATP, but the advantages it confers to cancer cells remain to be fully explained. Several oncogenic signaling pathways, interplaying with enzymes and kinases involved in glucose metabolism, participate in the switch from oxidative phosphorylation (OXPHOS) to aerobic glycolysis. Non-coding RNAs (ncRNAs) are a family of functional RNA molecules that are not further translated into proteins, which exert regulatatory roles in gene transcription and translation. ncRNAs, especially miRNAs and long non-coding RNAs (lncRNAs), may also have great effect on glucose metabolism by targeting not only glycolysis enzymes directly but also oncogenic signaling pathways indirectly. A better understanding of the Warburg effect and the regulatory role of ncRNAs in cancer glucose metabolism may contribute to the treatment of cancers.
Similar articles
-
Non-coding RNAs in the reprogramming of glucose metabolism in cancer.Cancer Lett. 2018 Apr 10;419:167-174. doi: 10.1016/j.canlet.2018.01.048. Epub 2018 Jan 31. Cancer Lett. 2018. PMID: 29366802 Review.
-
Non-coding RNAs: Key regulators of aerobic glycolysis in breast cancer.Life Sci. 2020 Jun 1;250:117579. doi: 10.1016/j.lfs.2020.117579. Epub 2020 Mar 21. Life Sci. 2020. PMID: 32209425 Review.
-
The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancer.Semin Cancer Biol. 2023 Oct;95:1-12. doi: 10.1016/j.semcancer.2023.06.007. Epub 2023 Jun 25. Semin Cancer Biol. 2023. PMID: 37364663 Review.
-
Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect.Mol Ther Oncolytics. 2020 Oct 10;19:218-239. doi: 10.1016/j.omto.2020.10.003. eCollection 2020 Dec 16. Mol Ther Oncolytics. 2020. PMID: 33251334 Free PMC article. Review.
-
Regulation of aerobic glycolysis by long non-coding RNAs in cancer.Biochem Biophys Res Commun. 2016 Oct 7;479(1):28-32. doi: 10.1016/j.bbrc.2016.09.007. Epub 2016 Sep 3. Biochem Biophys Res Commun. 2016. PMID: 27596968 Review.
Cited by
-
The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors.Molecules. 2023 Dec 22;29(1):75. doi: 10.3390/molecules29010075. Molecules. 2023. PMID: 38202657 Free PMC article. Review.
-
RGD-PEG-PLA Delivers MiR-133 to Infarct Lesions of Acute Myocardial Infarction Model Rats for Cardiac Protection.Pharmaceutics. 2020 Jun 21;12(6):575. doi: 10.3390/pharmaceutics12060575. Pharmaceutics. 2020. PMID: 32575874 Free PMC article.
-
A feedback loop between NONHSAT024276 and PTBP1 inhibits tumor progression and glycolysis in HCC by increasing the PKM1/PKM2 ratio.Cancer Sci. 2023 Apr;114(4):1519-1540. doi: 10.1111/cas.15697. Epub 2022 Dec 27. Cancer Sci. 2023. PMID: 36529521 Free PMC article.
-
Large Intergenic Non-coding RNA-RoR Inhibits Aerobic Glycolysis of Glioblastoma Cells via Akt Pathway.J Cancer. 2018 Feb 23;9(5):880-889. doi: 10.7150/jca.20869. eCollection 2018. J Cancer. 2018. PMID: 29581766 Free PMC article.
-
Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.Int J Mol Sci. 2017 Nov 7;18(11):2355. doi: 10.3390/ijms18112355. Int J Mol Sci. 2017. PMID: 29112161 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources